Neville Rodie & Shaw’s Amgen AMGN Stock Holding History

Neville Rodie & Shaw’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$737K	Sell	2,035 -1,100	-35%	-$377K	0.05%	149
2026 Q1	$1.1M	Hold	3,135	–	–	0.08%	123
2025 Q4	$1.03M	Buy	3,135 +225	+8%	+$71.4K	0.07%	121
2025 Q3	$821K	Hold	2,910	–	–	0.06%	144
2025 Q2	$813K	Sell	2,910 -880	-23%	-$249K	0.06%	141
2025 Q1	$1.18M	Buy	3,790 +160	+4%	+$47.2K	0.09%	120
2024 Q4	$946K	Buy	3,630 +2,200	+154%	+$653K	0.07%	134
2024 Q3	$461K	Buy	1,430 +230	+19%	+$75.2K	0.03%	187
2024 Q2	$375K	Hold	1,200	–	–	0.03%	200
2024 Q1	$341K	Hold	1,200	–	–	0.03%	210
2023 Q4	$346K	Hold	1,200	–	–	0.03%	203
2023 Q3	$322K	Hold	1,200	–	–	0.03%	206
2023 Q2	$266K	Sell	1,200 -150	-11%	-$34.8K	0.02%	224
2023 Q1	$327K	Sell	1,350 -180	-12%	-$44.2K	0.03%	208
2022 Q4	$402K	Hold	1,530	–	–	0.04%	197
2022 Q3	$345K	Hold	1,530	–	–	0.03%	202
2022 Q2	$373K	Hold	1,530	–	–	0.03%	199
2022 Q1	$372K	Hold	1,530	–	–	0.03%	211
2021 Q4	$344K	Sell	1,530 -175	-10%	-$36.9K	0.02%	214
2021 Q3	$363K	Sell	1,705 -26	-2%	-$5.98K	0.03%	206
2021 Q2	$422K	Hold	1,731	–	–	0.03%	196
2021 Q1	$430K	Hold	1,731	–	–	0.04%	194
2020 Q4	$398K	Buy	1,731 +130	+8%	+$30K	0.03%	194
2020 Q3	$407K	Buy	1,601 +124	+8%	+$30.7K	0.04%	180
2020 Q2	$349K	Hold	1,477	–	–	0.04%	182
2020 Q1	$300K	Hold	1,477	–	–	0.04%	180
2019 Q4	$356K	Hold	1,477	–	–	0.03%	193
2019 Q3	$286K	Hold	1,477	–	–	0.03%	206
2019 Q2	$272K	Hold	1,477	–	–	0.03%	212
2019 Q1	$281K	Buy	1,477 +26	+2%	+$4.96K	0.03%	211
2018 Q4	$282K	Hold	1,451	–	–	0.03%	195
2018 Q3	$300K	Hold	1,451	–	–	0.03%	212
2018 Q2	$268K	Hold	1,451	–	–	0.03%	217
2018 Q1	$247K	Hold	1,451	–	–	0.03%	220
2017 Q4	$253K	Hold	1,451	–	–	0.03%	222
2017 Q3	$271K	Hold	1,451	–	–	0.03%	212
2017 Q2	$250K	Hold	1,451	–	–	0.03%	220
2017 Q1	$238K	Hold	1,451	–	–	0.03%	231
2016 Q4	$213K	Sell	1,451 -592	-29%	-$89.1K	0.03%	241
2016 Q3	$341K	Hold	2,043	–	–	0.04%	205
2016 Q2	$310K	Hold	2,043	–	–	0.04%	218
2016 Q1	$307K	Hold	2,043	–	–	0.04%	212
2015 Q4	$332K	Hold	2,043	–	–	0.04%	208
2015 Q3	$283K	Hold	2,043	–	–	0.03%	221
2015 Q2	$314K	Hold	2,043	–	–	0.03%	217
2015 Q1	$327K	Sell	2,043 -99	-5%	-$15.6K	0.03%	218
2014 Q4	$341K	Sell	2,142 -54	-2%	-$8.41K	0.03%	213
2014 Q3	$309K	Buy	2,196 +54	+3%	+$7.05K	0.03%	220
2014 Q2	$253K	Sell	2,142 -778	-27%	-$90.1K	0.03%	233
2014 Q1	$360K	Sell	2,920 -50	-2%	-$6.06K	0.04%	188
2013 Q4	$339K	Sell	2,970 -10	-0.3%	-$1.14K	0.04%	189
2013 Q3	$333K	Sell	2,980 -90	-3%	-$9.76K	0.04%	190
2013 Q2	$303K	Buy	+3,070	New	+$319K	0.04%	198

Other funds holding AMGN

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFM

Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Neville Rodie & Shaw's AMGN Position: Q2 2026 in Review

Neville Rodie & Shaw reduced its Amgen (AMGN) stake by 35% in Q2 2026, selling an estimated $377K and leaving 2,035 shares worth $737K. The position accounts for 0.05% of the portfolio, ranked #149.

Neville Rodie & Shaw first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.18M in Q1 2025. 1,293 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Neville Rodie & Shaw held 2,035 shares of Amgen worth $737K as of Q2 2026.
Neville Rodie & Shaw sold 1,100 Amgen shares in Q2 2026, an estimated $377K.
Amgen made up 0.05% of Neville Rodie & Shaw's portfolio in Q2 2026, its #149 holding.
Neville Rodie & Shaw first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
Neville Rodie & Shaw's Amgen position peaked at $1.18M in Q1 2025.
1,293 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Neville Rodie & Shaw's 13F filing for Q2 2026, filed 6 Jul 2026.